State medical marijuana laws continue to expand March 29, 2017 By Bryant Furlow Medical marijuana’s therapeutic evidence base remains nascent and controversial but the regulatory landscape is evolving rapidly. Cannabinoid-based drug pipeline shows promise New treatment indications are under investigation for the use of cannabinoid-based drugs. Cannabinoid-based drug pipeline grows: 4 ways to prepare New treatment indications are under investigation for the use of cannabinoid-based drugs. Are you ready? How marijuana promoters bypass the law — and the public good If you think legalization of marijuana is such a good thing, take a look at what's been going on in Colorado. Top 6 new facts on drug overdoses November 04, 2015 By Christine Blank Deaths from drug overdoses are the leading cause of injury death in the United States, ahead of deaths linked to motor vehicles and firearms, according to the new 2015 National Drug Threat Assessment (NDTA), released by the Drug Enforcement Administration. Marijuana’s role in optometry and beyond Bob Prouty, OD, FAAO, educated a packed house at the American Optometirc Association’s Optometry’s Meeting on marijuana’s use in and outside of eye care. Cannabinoids: medical perils and benefits November 12, 2014 By Colleen E. McCarthy During the American Academy of Optometry's Academy 2014, panelists outlined the promise and potential pitfalls of cannabinoid-based therapies. 4 drug categories to know to better manage itch March 24, 2014 By John Jesitus Selecting the appropriate drug category is important to effectively manage itch, Sarina Elmariah, M.D., Ph.D., told attendees at the 72nd Annual Meeting of the American Academy of Dermatology.